ReviewCurrent oncology (Toronto, Ont.)2023
Efficacy and Safety of Anti-HER2 Targeted Therapy for Metastatic HR-Positive and HER2-Positive Breast Cancer: A Bayesian Network Meta-Analysis.
Xian-Meng Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.